Abstract
The primary role of the obstetrician/gynecologist in the management of hypertension in the past was obstetrical-related hypertension. The role of the gynecologist in overall health care maintenance and disease prevention is expanding and the recognition and treatment of hypertension should be considered in this role. Hypertension is a primary cause of cardiovascular disease, which remains a significant cause of morbidity and mortality in women. More than 60 million persons in the United States have some degree of hypertension, with an incidence of 65% between the ages of 65 and 74 years. The contribution of hypertension to overall cardiovascular morbidity and mortality in women has been considered less important than in men, but this absence of data may be the result of gender bias. Cardiovascular disease is in many cases the manifestation of multiple risk factors including obesity, hyperlipidemia, hypertriglyceridemia, type 2 diabetes, and hyperinsulinemia. Hypertension continues as the most prevalent associated factor in cardiovascular disease and in many cases coexists with other risk factors. Hypertension awareness has resulted in the lowering of average blood pressure in the United States over the past several decades.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
Anastos K, Charney P, Charon RA, et al. Hypertension in women: what is really known. Ann Intern Med 1991;115:287–93.
Cappuccio FP, Siani A, Strazzullo P. Oral calcium supplementation and blood pressure: an overview of randomized controlled trials. J Hypertens 1989;7:941–46.
Cubeddu LX, Aranda I, Singh B, et al. A comparison of verapamil and propranolol for the initial treatment of hypertension: racial differences in response. JAMA 1986;256:2214–21.
Dwyer PL, Teele IS. Prazosin: a neglected cause of genuine stress incontinence. Obstet Gynecol 1992;79:117–21.
Folsom AR, Luepker RV, Gillum RF, et al. Improvement in hypertension detection and control from 1973-74 to 1980-81: the Minnesota Heart Survey experience. JAMA 1983;250:916–21.
Frishman WH. Beta-adrenergic blocker withdrawal. Am J Cardiol 1987;59:26F–32F.
Frost CD, Law MR, Wald NI. By how much does dietary salt reduction lower blood pressure? II. Analysis of observational data within populations. BMJ 1991;302:815–18.
Gillum RF, Prineas RI, Ieffery RW, et al. Nonpharmacological therapy of hypertension: the independent effect of weight reduction and sodium restriction in overweight borderline hypertensive patients. Am Heart J 1983;105:128–33.
Havlik RI, Hubert HB, Fabsitz RR, et al. Weight and hypertension. Ann Intern Med 1983;98:855–59.
Karvonen M, Ormo E, Keys A, et al. Cigarette smoking, serum cholesterol, blood pressure and body fitness: observations in Finland. Lancet 1959;i:492–94.
Krishna GC, Miller E, Kapoor S. Increased blood pressure during potassium depletion in normotensive men. N Engl J Med 1989;320:1177–82.
Lesniak KT, Dubbert PM. Exercise and hypertension. Curr Opinion Cardiol 2001;16:356–9.
Liu K, Ruth K, Flack I, et al. Ethnic difference in 5-year blood pressure change in young adults: the CARDIA study. Circulation 1992;85:6A.
Mancia G, Bertinieri G, Grassi G, et al. Effects of blood pressure measurement by the doctor on patient’s blood pressure and heart rate. Lancet 1983;ii:695–98.
Marmot M, Brunner E. Alcohol and cardiovascular disease: the status of the U shaped curve. BMJ 1991;303:565–68.
Marmot MG, Rose G, Shipley MI, et al. Alcohol and mortality: a U-shaped curve. Lancet 1981;i:580–83.
McAlister FA, Campbell NRC, Zarnke K, Levine M, Graham ID. The management of hypertension in Canada; a review of current guidelines, their shortcomings and implications for the future. CMAJ 2001;164(4):517–22.
McAlister FA, Straus SE. Evidence based treatment of hypertension. Measurement of blood pressure: an evidence based review. BMJ 2001;322:908–11.
McCarron DA, Henry HI, Morris CD. Human nutrition and blood pressure regulation: an integrated approach. Hypertension 1992;4:2S–13S.
Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol in the treatment of mild hypertension. Lancet 1981;ii:539–43.
Morris MC, Sacks FM. Dietary fats and blood pressure. In Textbook of Hypertension. JD Swales (ed). Oxford, England: Blackwell Scientific; 1994, pp 605–18.
O’Brien E, Atkins N, Mee F, et al. Comparative accuracy of six ambulatory devices according to blood pressure levels. J Hypertens 1993;11:673–75.
Pan WH, Nanas S, Dyer A, et al. The role of weight in the positive association between age and blood pressure. Am J Epidemiol 1986;124:612–23.
Pool JL, Lenz ML, Taylor AA. Alpha:1-adrenoceptor blockade and the molecular basis of lipid metabolism alterations. J Hum Hypertens 1990;4:23–33.
Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620–25.
Roberts I, Maurer K. Blood pressure levels of persons 6–74 years, United States, 1971–74. Vital and Health Statistics, Series 11, 203. National Center for Health Statistics. Washington, DC: US Government Printing Office, 1977, DHEW Publication No. (HRA) 78-1648.
Selby IV, Friedman GD, Quesenberry CP Jr. Precursors of essential hypertension: the role of body fat distribution pattern. Am J Epidemiol 1989;129:43–53.
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII). JAMA 2003;289:2560–72.
Sever PS, Poulter NR. A hypothesis for the pathogenesis of essential hypertension: the initiating factors. J Hypertens 1989;7:9S–12S.
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265:3255–64.
Siani A, Strazullo P, Giogione N, et al. Increasing dietary potassium intake reduces the need for antihypertensive medication. Am J Hypertens 1990;3:110A.
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Ach Intern Med 1997;157:2413–46. NIH publication No. 98-4080.
Stampfer MI, Colditz GA, Willard WO, et al. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988;319:267–73.
Swales JD. Angiotensin-converting enzyme inhibitors. In Textbook of Hypertension. JD Swales (ed). Oxford, England: Blackwell Scientific; 1994, pp 1115–27.
Truswell AS, Kennelly BM, Hansen IDL, et al. Blood pressure of Kung bushmen in northern Botswana. Am Heart J 1972;84:5–12.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Daberkow, D.W., Nolan, T.E. (2007). Cardiovascular Hypertension. In: Primary Care in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-32328-2_10
Download citation
DOI: https://doi.org/10.1007/978-0-387-32328-2_10
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-32327-5
Online ISBN: 978-0-387-32328-2
eBook Packages: MedicineMedicine (R0)